This is a feasibility and pilot study to refine and test LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app, integrated into the patient's personal electronic device, to augment and facilitate communication in patients with tumor-related aphasia (TRA) and their care partners. The study will assess the feasibility and acceptability of LISTEN in patients with TRA and their care partners.
Inclusion Criteria:
Patient inclusion criteria are as follows:
Care-partner inclusion criteria are as follows:
Exclusion Criteria:
Patient exclusion criteria are as follows:
Care-partner exclusion criteria are as follows:
-Unable to read or respond to questions in English
John_Rhee@DFCI.HARVARD.EDU(857) 215-3308
Refinement Phase - 10 patient-care-partner dyads (20 participants) will use the LISTEN prototype in a single session for usability testing.
Pre-pilot Phase - 10 patient-care-partner dyads (20 participants) will use LISTEN in real-world scenarios for iterative refinement.
Open Pilot Phase - 20 patient-care-partner dyads (40 participants) will use LISTEN for up to 16 weeks to assess feasibility and acceptability.
Boston, Massachusetts 02115, United States
John_Rhee@dfci.harvard.edu(857) 215-3308
John_Rhee@dfci.harvard.edu(857) 215-3308
John_Rhee@dfci.harvard.edu(857) 215-3308
John_Rhee@dfci.harvard.edu(857) 215-3308
Listen in: Developing and Testing a Therapy Application for Patients With Speech Comprehension Deficits After Stroke.
Remote Monitoring and Symptom Management Digital Application
Assistant for LIstening and Communication Enhancement
Study of Attention and Memory Treatments for Cancer Survivors
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment
Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate Cancer
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort